PL1838392T3 - Leki zawierające selen na śródbłonkowe choroby układu naczyniowego - Google Patents

Leki zawierające selen na śródbłonkowe choroby układu naczyniowego

Info

Publication number
PL1838392T3
PL1838392T3 PL06700374T PL06700374T PL1838392T3 PL 1838392 T3 PL1838392 T3 PL 1838392T3 PL 06700374 T PL06700374 T PL 06700374T PL 06700374 T PL06700374 T PL 06700374T PL 1838392 T3 PL1838392 T3 PL 1838392T3
Authority
PL
Poland
Prior art keywords
selenium
prevention
treatment
vascular diseases
endothelial vascular
Prior art date
Application number
PL06700374T
Other languages
English (en)
Inventor
Thomas Stiefel
Original Assignee
Biosyn Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosyn Arzneimittel Gmbh filed Critical Biosyn Arzneimittel Gmbh
Publication of PL1838392T3 publication Critical patent/PL1838392T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06700374T 2004-12-31 2006-01-02 Leki zawierające selen na śródbłonkowe choroby układu naczyniowego PL1838392T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004063638A DE102004063638A1 (de) 2004-12-31 2004-12-31 Selen-haltige Medikamente zur Prophylaxe oder Therapie von endothelialen Gefäßerkrankungen
EP06700374A EP1838392B1 (de) 2004-12-31 2006-01-02 Selen-haltige medikamente gegen endotheliale gefässerkrankungen
PCT/EP2006/000007 WO2006070022A2 (de) 2004-12-31 2006-01-02 Selen-haltige medikamente gegen endotheliale gefasserkrankungen

Publications (1)

Publication Number Publication Date
PL1838392T3 true PL1838392T3 (pl) 2011-09-30

Family

ID=36129753

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06700374T PL1838392T3 (pl) 2004-12-31 2006-01-02 Leki zawierające selen na śródbłonkowe choroby układu naczyniowego

Country Status (8)

Country Link
EP (1) EP1838392B1 (pl)
AT (1) ATE503527T1 (pl)
DE (2) DE102004063638A1 (pl)
DK (1) DK1838392T3 (pl)
ES (1) ES2360886T3 (pl)
PL (1) PL1838392T3 (pl)
PT (1) PT1838392E (pl)
WO (1) WO2006070022A2 (pl)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1112164A (en) * 1977-08-02 1981-11-10 Joseph R. Levitt Therapeutic selenium compositions and the use thereof
DE4335441A1 (de) * 1993-10-18 1995-04-20 Hans Dipl Chem Heide Mittel zur Gesundheitsvorsorge im Herz- Kreislaufsystem beim Menschen
WO1995029684A1 (en) * 1994-05-02 1995-11-09 Abbott Laboratories Inhibition of atherosclerosis by antioxidants
US5929063A (en) * 1995-03-24 1999-07-27 Children's Hospital Medical Center Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
WO2001089542A2 (en) * 2000-05-25 2001-11-29 Pharmaton S.A. Composition for improving the cell protection comprising a lipophilic antioxidant and a hydrophilic antioxidant
WO2002067853A2 (en) * 2000-10-06 2002-09-06 Probiochem, Llc A combination and method of treatment of hiv and viral diseases, vascular disease and cancer utilizing a cox-2 inhibitor and cystine
US20020182585A1 (en) * 2001-01-10 2002-12-05 George Kindness Combination and method using EDTA, cystine, zinc and selenium for anti-thrombin effect and for anti-platelet aggregation and measurement of efficacy
DE10321029A1 (de) * 2003-05-10 2004-12-02 Sigrid Heide Arzneimittel mit Selenit
US20060166957A1 (en) * 2003-06-12 2006-07-27 Menachem Rubinstein Methods of treating obesity and related disorders using tellurium selenium compounds
WO2005023274A1 (en) * 2003-09-05 2005-03-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
ITRM20040395A1 (it) * 2004-08-03 2004-11-03 Sigma Tau Ind Farmaceuti Composizione comprendente statine e acidi grassi omega 3.
DE102004040006A1 (de) * 2004-08-18 2006-03-09 Kurt Mosetter Pharmazeutische Zusammensetzung, umfassend Galaktose, Selen, Vitamin E und/oder Phosphatidylcholin und pharmazeutische Verwendung von Galaktose

Also Published As

Publication number Publication date
WO2006070022A3 (de) 2007-04-19
DE502006009204D1 (de) 2011-05-12
DE102004063638A1 (de) 2006-07-13
WO2006070022A2 (de) 2006-07-06
ATE503527T1 (de) 2011-04-15
EP1838392B1 (de) 2011-03-30
EP1838392A2 (de) 2007-10-03
ES2360886T3 (es) 2011-06-10
PT1838392E (pt) 2011-04-29
DK1838392T3 (da) 2011-06-27

Similar Documents

Publication Publication Date Title
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
SG148177A1 (en) Novel cis-imidazolines
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
IL175762A0 (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
MX2007012538A (es) Uso de lactobacillus gg en la manufactura de un medicamento para la prevencion o tratamiento de alergias respiratorias.
UA94580C2 (ru) Аналог 39-дезметоксирапамицина, способный преодолевать гематоэнцефалический барьер, для лечения патологического состояния, вызванного нейрогенным повреждением или заболеванием
MX2010006204A (es) Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
TW200626158A (en) Naphthaline derivatives
HK1104460A1 (en) Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
TW200724146A (en) Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
WO2008046407A3 (de) Verwendung von deuteriumdioxid zur behandlung von hyperproliferativen erkrankungen der haut
PT1778837E (pt) Tratamento de doenças neurodegenerativas por utilização de inibidores de scd4
WO2008125800A3 (en) Mmp activated vascular disrupting agents
MX2008001506A (es) Uso de sales de triotropio en el tratamiento de asma severa persistente.
PL1838392T3 (pl) Leki zawierające selen na śródbłonkowe choroby układu naczyniowego
UA99093C2 (ru) Применение фенофибрата или его производного для лечения диабетической ретинопатии
MX2007004040A (es) Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.
TW200621794A (en) Pulmonary administration of an antithrombotic compound
WO2007109275A3 (en) Paclitaxel combination